An HIV Wave Hitting Only One Side of the Market: Women in Mat South Are Bearing the Brunt

By Michael Gwarisa in Mat South In Matabeleland South, the burden of new HIV infections falls almost exclusively on women. The numbers are more than statistics; they depict a crisis where mothers and daughters are diagnosed one after the other, while men’s rates lag behind. This imbalance is shrinking families, disrupting livelihoods, and leaving communities to pick up the pieces. Data from the 2022 National Housing and Population Census shows that Matabeleland South has an estimated population of 760,000 people. Of these, the National AIDS Council (NAC) estimates that 93,000…

Read More

United Nations Proposes Shutting Down UNAIDS In 2026

By Staff Reporter  The United Nations (UN) agency focusing on the HIV/AIDS pandemic could close by the end of next year as the UN restructures in the face of a funding crisis, according to a UN document published online. UNAIDS will “sunset” by the end of 2026, the document published on Thursday reads, part of a set of proposals from the UN to member states which they will have to decide on. It adds that UNAIDS’ expertise should be shifted into the wider UN system in the following year. The…

Read More

Zimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir

By Michael Gwarisa  Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…

Read More